Patient-centred newer testing methods for major cardiac disorders

Area of Science:

• Biochemistry
• Medical Diagnostics
• Biotechnology

Background:

• Cardiac diseases represent a growing global health burden, necessitating efficient diagnostic tools.
• Traditional laboratory testing for cardiac biomarkers can lead to delays in diagnosis and treatment.
• Point-of-care testing (POCT) offers a promising alternative for rapid, accessible cardiac biomarker analysis.

Purpose of the Study:

• To review current point-of-care testing (POCT) methods for cardiac biomarkers.
• To evaluate the diagnostic role of POCT in major cardiac conditions.
• To explore future developments, including AI-enhanced biosensors, in cardiac diagnostics.

Main Methods:

• A narrative review of existing literature and clinical trials.
• Searches conducted across major online databases for relevant studies.
• Assessment of compiled information using the Scale for the Assessment of Narrative Review Articles (SANRA).

Main Results:

• POCT methods provide rapid detection of cardiac biomarkers, crucial for timely diagnosis and management.
• These methods are particularly valuable in resource-constrained areas, overcoming limitations of traditional labs.
• Emerging AI-integrated biosensors show potential for earlier results and improved clinical decision-making.

Conclusions:

• POCT is a vital tool for improving cardiac care, offering speed and accessibility.
• AI integration in biosensors represents a significant advancement for cardiac diagnostics.
• Further research and clinical trials are essential to fully realize the potential of these evolving technologies.